• BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

    Источник: Buzz FX / 06 янв 2025 03:30:14   America/New_York


    BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat January 6, 2025 Share Link copied to clipboard. BridgeBio Pharma, Inc. ( NASDAQ:BBIO - Get Free Report ) has been
    Read more...
Опубликовать